Pliant Therapeutics
Pliant Therapeutics is a clinical-stage biopharmaceutical company developing treatments for fibrotic diseases with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.
All edits by Даниил Талан
Pliant Therapeutics
Treatments for fibrotic diseases
Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.
Reaching New Destinations
Pliant Therapeutics is a clinical-stage biopharmaceutical company leading the way in developing new treatments for fibrotic diseases. As fibrosis is a complex disease, few available treatments for fibrosis exist today. We are committed to advancing novel treatments and prepared to change the fibrosis treatment landscape.
Pliant is diving deep to understand the molecular drivers of fibrotic diseases to unlock potentially safer, and more effective therapies for patients.
Mission
Build the leading fibrosis company by combining world class expertise in fibrosis-biology, chemistry and technology to develop best-in-class,
tissue-specific, inhibitors of fibrotic diseases.
February 24, 2022
February 24, 2022
Find more companies like Pliant Therapeutics
